5 of 101 shown

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

There are two charts here because there are two different amounts. A lobbying firm reports income: what it was paid. A company that lobbies for itself reports expenses: what it spent, under one of three accounting methods it picks itself. Both appear under this company, and they are not the same measurement — so they are never added, not in a bar and not in a total.

Reported income: what lobbying firms reported receiving from this company's clients, per quarter.

Reported expenses: what this company reported spending on its own lobbying, per quarter, under the accounting method it picked itself.

Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.

Reported income

Q1Q2Q3Q4
$0$250k$500k2013: no report held for Q1, $0 Q2, $0 Q3, $10k Q420132014: $30k Q1, $30k Q2, $30k Q3, $30k Q420142015: $30k Q1, $30k Q2, $30k Q3, $30k Q420152016: $30k Q1, $30k Q2, $30k Q3, $30k Q420162017: $30k Q1, $30k Q2, $30k Q3, $30k Q420172018: $0 Q1, $0 Q2, $0 Q3, $0 Q420182019: $0 Q1, $0 Q2, $0 Q3, $0 Q420192020: $0 Q1, $0 Q2, $0 Q3, $0 Q420202021: $0 Q1, $0 Q2, $0 Q3, $0 Q420212022: $0 Q1, $0 Q2, $0 Q3, $0 Q420222023: $0 Q1, $70k Q2, $50k Q3, $50k Q420232024: $50k Q1, $50k Q2, $50k Q3, $50k Q420242025: $50k Q1, $50k Q2, $80k Q3, $80k Q420252026: $50k Q1, $50k Q2, $50k Q32026

Reported expenses

Q1Q2Q3Q4
$0$1M$2M2013: no report held for Q1, $10k Q2, $30k Q3, $30k Q420132014: $60k Q1, $60k Q2, $50k Q3, $120k Q420142015: $60k Q1, $50k Q2, $60k Q3, $60k Q420152016: $80k Q1, $90k Q2, $120k Q3, $210k Q420162017: $280k Q1, $350k Q2, $150k Q3, $290k Q420172018: $250k Q1, $110k Q2, $120k Q3, $340k Q420182019: $410k Q1, $110k Q2, $160k Q3, $390k Q420192020: $370k Q1, $250k Q2, $230k Q3, $510k Q420202021: $390k Q1, $190k Q2, $190k Q3, $270k Q420212022: $560k Q1, $220k Q2, $170k Q3, $420k Q420222023: $420k Q1, $210k Q2, $220k Q3, $470k Q420232024: $410k Q1, $180k Q2, $240k Q3, $490k Q420242025: $390k Q1, $270k Q2, $270k Q3, $390k Q420252026: $530k Q1, $340k Q2, $200k Q32026

Recent activity

Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.

8 superseded versions left out of the quarterly sums, listed here.

5 of 101 filings
The most recently posted lobbying filings for BMRN
RegistrantFilingAmountPosted RegistrantAmountFilingAll amountsPosted
BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.3rd Quarter - Report3rd Quarter 2026$200,000expenses (A)posted Oct 20, 2026 (LD-2 at lda.gov)Oct 20, 2026 (LD-2 at lda.gov)BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.$200,000expenses (A) · Oct 203rd Quarter - Report3rd Quarter 2026$200,000expenses (A)Oct 20, 2026 (LD-2 at lda.gov)
BGR GOVERNMENT AFFAIRSfor BIOMARIN PHARMACEUTICAL INC.3rd Quarter - Report3rd Quarter 2026$50,000incomeposted Oct 20, 2026 (LD-2 at lda.gov)Oct 20, 2026 (LD-2 at lda.gov)BGR GOVERNMENT AFFAIRSfor BIOMARIN PHARMACEUTICAL INC.$50,000income · Oct 203rd Quarter - Report3rd Quarter 2026$50,000incomeOct 20, 2026 (LD-2 at lda.gov)
BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.2nd Quarter - Amendment2nd Quarter 2026$340,000expenses (A)posted Jul 20, 2026 (LD-2 at lda.gov)Jul 20, 2026 (LD-2 at lda.gov)BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.$340,000expenses (A) · Jul 202nd Quarter - Amendment2nd Quarter 2026$340,000expenses (A)Jul 20, 2026 (LD-2 at lda.gov)
BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.2nd Quarter - Amendment2nd Quarter 2026superseded by a later version$340,000expenses (A)posted Jul 20, 2026 (LD-2 at lda.gov)Jul 20, 2026 (LD-2 at lda.gov)BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.$340,000expenses (A) · Jul 202nd Quarter - Amendment2nd Quarter 2026 · superseded$340,000expenses (A)Jul 20, 2026 (LD-2 at lda.gov)
BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.2nd Quarter - Report2nd Quarter 2026superseded by a later version$340,000expenses (A)posted Jul 20, 2026 (LD-2 at lda.gov)Jul 20, 2026 (LD-2 at lda.gov)BIOMARIN PHARMACEUTICAL INC.for BIOMARIN PHARMACEUTICAL INC.$340,000expenses (A) · Jul 202nd Quarter - Report2nd Quarter 2026 · superseded$340,000expenses (A)Jul 20, 2026 (LD-2 at lda.gov)

The link between the client names above and BMRN is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.